VINCENT A MILLER, MD
Osteopathic Medicine at York Ave, New York, NY
License number
New York 192263
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address
1275 York Ave, New York, NY 10021
Phone
(646) 227-3275
Personal information
See more information about VINCENT A MILLER at radaris.comName
Address
Phone
4741 Matilda Ave #2, Bronx, NY 10470
59 Montgomery St, Poughkeepsie, NY 12601
544 Roberts Ave, Syracuse, NY 13207
395 Ocean Ave APT 4G, Brooklyn, NY 11226
3 Scotts Cove Ln, Setauket, NY 11733
Organization information
See more information about VINCENT A MILLER at bizstanding.comVINCENT MILLER
309 W 57 St #701A, New York, NY 10018
Site:
Phone:
(212) 664-9120 (Phone)
Email:
Vincent A Miller MD
300 E 66 St, New York, NY 10065
Categories:
Physicians & Surgeons
Phone:
(646) 227-3700 (Phone)
Professional information
Software Architect/Developer
Position:
Lead Developer/Architect at
Location:
Greater New York City Area
Industry:
Computer Software
Work:
since Jul 2011
-
Lead Developer/Architect
RVM Inc.
Nov 2010 - Jul 2011
-
Software Architect/Senior Developer
Vin Miller Consulting
May 2000 - Nov 2010
-
VinMiller Consulting
InvestLink Technologies
1997 - 2001
-
Managing Director of Software Development
MDRC
1996 - 1997
-
Information Services Analyst
Population Council
1992 - 1995
-
Data Management Analyst
Gay Men's Health Crisis
Oct 1990 - Sep 1992
-
Assistant Coordinator of Management Information Systems
Education:
Boston College 1986 - 1990
BA, History
BA, History
Skills:
Microsoft SQL Server, .NET, C#, ASP.NET, VB.NET, Databases, JavaScript, WCF, Agile Methodologies, Web Services, Visual Basic, jQuery, IIS, CSS, Scrum, ASP, Web Development, OOP
Interests:
Music, US Presidential History, Baseball.
Dr. Vincent Miller, New York NY - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
MSKCC
1275 York Ave, New York 10065
(866) 425-8999 (Phone)
1275 York Ave, New York 10065
(866) 425-8999 (Phone)
Certifications:
Internal Medicine, 1990, Medical Oncology, 1995
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
MSKCC
1275 York Ave, New York 10065
Memorial Sloan - Kettering Cancer Center
1275 York Ave, New York 10065
1275 York Ave, New York 10065
Memorial Sloan - Kettering Cancer Center
1275 York Ave, New York 10065
Philosophy:
I am a medical oncologist who specializes in treating patients with lung cancer. I have a particular interest in understanding the differences in lung cancer between both former and current smokers and patients who have never smoked. I also have a special interest in the treatment of bronchiolo-alveolar cell carcinoma (BAC). This type of lung cancer has a unique clinical behavior, and my Memorial Sloan-Kettering Cancer Center colleagues and I have been leaders in bringing targeted therapies -- such as erlotinib (OSI-774) and gefitinib (Iressa) -- to patients with BAC.
Education:
Medical School
Umdnj--Robert Wood Johnson Medical School
Graduated: 1987
Umdnj--Robert Wood Johnson Medical School
Graduated: 1987
Owner, Creative Engineering,Inc /Ce Space Planning,Inc
Position:
Owner at Creative Engineering Inc.
Location:
Greater New York City Area
Industry:
Entertainment
Work:
Creative Engineering Inc.
- Long Island City, New York since Jun 1990
-
Owner
Skills:
Retail, Furniture, Scheduling, Materials, Creative Development, Film, Drawing, Fashion, Hotels, Interior Design, Renovation, Space Planning, Interiors, Event Management, House, Event Planning, Construction, Trade Shows, Promotions, Advertising, Lighting, Photography, Furnishings, Cabinetry
At Trainhard Fitness
Position:
Owner at TrainHard Fitness
Location:
Greater New York City Area
Industry:
Health, Wellness and Fitness
Work:
TrainHard Fitness
since Jul 2008
-
Owner
Equinox
May 2004 - Sep 2008
-
Tier 3 Personal Trainer
Vincent Amory Miller, New York NY
Specialties:
General Practice, Internal Medicine, Medical Oncology, Hematology & Oncology
Work:
Memorial Sloan-Kettering
1275 York Ave, New York, NY 10065
1275 York Ave, New York, NY 10065
Education:
UMDNJ (1987)
Vincent A Miller, New York NY
Specialties:
Oncologist
Address:
1275 York Ave, New York, NY 10065
633 3Rd Ave, New York, NY 10017
633 3Rd Ave, New York, NY 10017
Education:
University of Medicine and Dentistry of New Jersey, New Jersey Medical School - Doctor of Medicine
University of Pennsylvania - Bachelor of Arts (BA)
University of Pennsylvania - Bachelor of Arts (BA)
Board certifications:
American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
V.p., Cco At Moflavor
Position:
V.P., CCO at MoFlavor
Location:
Greater New York City Area
Industry:
Entertainment
Work:
MoFlavor
-
V.P., CCO
Skills:
Music, Music Production, Public Speaking
Vincent Miller
Location:
Greater New York City Area
Industry:
Investment Management
Skills:
Investments, Hedge Funds, Asset Managment, Equities, Strategic Financial Planning, Financial Analysis, Private Equity, Funding, Asset Management, Financial Services, Portfolio Management
Methods And Compositions For Detecting A Drug Resistant Egfr Mutant
US Patent:
8067175, Nov 29, 2011
Filed:
Feb 13, 2006
Appl. No.:
11/815985
Inventors:
Harold Varmus - New York NY, US
Katerina Politi - New York NY, US
William Pao - New York NY, US
Vincent Miller - New York NY, US
Katerina Politi - New York NY, US
William Pao - New York NY, US
Vincent Miller - New York NY, US
Assignee:
Memorial Sloan-Kettering Cancer Center - New York NY
International Classification:
C12Q 1/68
US Classification:
435 612
Abstract:
Polymerase chain reaction primers and methods directed to detecting the EGFR mutant C→T at the position corresponding to base 2369 of EGFR cDNA. The invention provides a PCR primer that hybridizes under suitable PCR conditions to a polynucleotide sequence 5′ in each respective strand to a mutation of an EGFR gene that encodes a substitution of threonine by methionine at position 790 of the EGFR polypeptide. The invention also provides a PCR primer hybridizes to a sequence that includes a mutant T at the position corresponding to base 2369 of EGFR cDNA but not to a second EGFR polynucleotide containing a wild type C. The invention provides several methods and kits for detecting a mutant epidermal growth factor receptor (EGFR) gene in a sample comprising probing the sample with a means for selectively detecting a nucleotide sequence comprising a mutant T at the position corresponding to base 2369 of EGFR cDNA, and identifying that the base at said position is T. These methods and kits are also useful to predict resistance to the therapeutic effects of gefitinib or erlotinib in a subject suffering from or suspected of having a cancer.
Methods And Compositions For Detecting A Drug Resistant Egfr Mutant
US Patent:
8501413, Aug 6, 2013
Filed:
Oct 17, 2011
Appl. No.:
13/275161
Inventors:
Harold Varmus - New York NY, US
Katerina Politi - New York NY, US
William Pao - New York NY, US
Vincent Miller - New York NY, US
Katerina Politi - New York NY, US
William Pao - New York NY, US
Vincent Miller - New York NY, US
Assignee:
Memorial-Sloan Kettering Cancer Center - New York NY
International Classification:
C12Q 1/68
US Classification:
435 612
Abstract:
Development of acquired resistance to the therapeutic effects of an epidermal growth factor (EGFR) tyrosine kinase inhibitor in a patient that is suffering from a cancer is predicted by:.